[3614] Vos, S JB., Xiong C., Visser P J., Jasielec M. S., Hassenstab J., Grant E. A., et al. (2013).  Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study. The Lancet Neurology. 12(10), 957 - 965.

[3126] Esparza, T. J., Zhao H., Cirrito J. R., Cairns N. J., Bateman R. J., Holtzman D. M., et al. (2012).  Amyloid-beta oligomerization in alzheimer dementia vs. high pathology controls. Annals of Neurology. n/a - n/a.

[2997] Bateman, R. J., Xiong C., Benzinger T. L. S., Fagan A. M., Goate A., Fox N. C., et al. (2012).  Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease. New England Journal of Medicine. 120723122607004 - 120723122607004.

[2257] Naj, A. C., Jun G., Beecham G. W., Wang L-S., Vardarajan B. N., Buros J., et al. (2011).  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 43(5), 436 - 441.